General Chapter
p (39)
- Prescription Container Labeling
- Probiotics Tests
- Physicochemical Analytical Procedures For Insulins
- Pyrogen Test
- Prekallikrein Activator
- Particle Size Distribution Estimation by Analytical Sieving
- Particulate Matter in Injections
- pH
- Pharmaceutical Compounding-Nonsterile Preparations
- Pharmaceutical Compounding - Sterile Preparations
- Powder Fineness
- Positron Emission Tomography Drugs for Compounding, Investigational, and Research Uses
- Polarography
- POROSIMETRY BY MERCURY INTRUSION
- Potency Assays to Evaluate Coagulation Factor VIII and Factor IX
- Porosity by Nitrogen Adsorption–Desorption
- Physical Environments That Promote Safe Medication Use
- PHARMACEUTICAL DOSAGE FORMS
- PHARMACEUTICAL CALCULATIONS IN PHARMACY PRACTICE
- Powder Flow
- Particle Size Analysis by Dynamic Light Scattering
- Prescription Balances and Volumetric Apparatus Used in Compounding
- Package Integrity Testing in the Product Life Cycle—Test Method Selection and Validation
- Package Integrity Leak Test Technologies
- PROBE TACK TEST
- Package Integrity Evaluation—Sterile Products
- PRION INACTIVATION
- Package Seal Quality Test Technologies
- PHYSICOCHEMICAL INTEGRATORS AND INDICATORS FOR STERILIZATION
- Pyrrolizidine Alkaloids as Contaminants
- PREPARATION OF BIOLOGICAL SPECIMENS FOR HISTOLOGIC AND IMMUNOHISTOCHEMICAL ANALYSIS
- Products for Nebulization—Characterization Tests
- Presentation of Aerodynamic Particle Size Distribution (APSD) Measurement Data for Orally Inhaled Products
- POSITRON EMISSION TOMOGRAPHY DRUGS-INFORMATION
- Protein Determination Procedures - General Chapters - United States Pharmacopeia USP 2025
- Propellants
- Pharmaceutical Foams—Product Quality Tests
- Packaging and Storage Requirements
- PLASMA SPECTROCHEMISTRY
